Providence Capital Advisors, LLC Thermo Fisher Scientific Inc. Transaction History

Providence Capital Advisors, LLC

$487 Million
Q3 2024

A detailed history of Providence Capital Advisors, LLC transactions in Thermo Fisher Scientific Inc. stock. As of the latest transaction made, Providence Capital Advisors, LLC holds 13,752 shares of TMO stock, worth $7.06 Million. This represents 1.75% of its overall portfolio holdings.

Number of Shares

13,752

Previous 10,456 31.52%

Holding current value

$7.06 Million

Previous $5.78 Million 47.11%

% of portfolio

1.75%

Previous 1.3%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$531.86 - $624.21 $1.75 Million - $2.06 Million	3,296 Added 31.52%	13,752 $8.51 Million
Q2 2024 Aug 14, 2024	BUY	$541.52 - $599.02 $55,776 - $61,699	103 Added 0.99%	10,456 $5.78 Million
Q1 2024 May 13, 2024	BUY	$528.82 - $599.43 $88,312 - $100,104	167 Added 1.64%	10,353 $6.02 Million
Q3 2023 Nov 13, 2023	SELL	$498.29 - $574.41 $17,938 - $20,678	-36 Reduced 0.35%	10,186 $5.16 Million
Q2 2023 Aug 10, 2023	BUY	$508.46 - $591.13 $43,727 - $50,837	86 Added 0.85%	10,222 $5.33 Million
Q1 2023 May 17, 2023	BUY	$535.0 - $604.82 $3.12 Billion - $3.53 Billion	5,832,353 Added 59380.5%	5,842,175 $3.37 Billion
Q1 2023 May 17, 2023	SELL	$535.0 - $604.82 $3.12 Billion - $3.53 Billion	-5,832,039 Reduced 99.83%	10,136 $5.84 Million
Q1 2023 May 10, 2023	BUY	$535.0 - $604.82 $201,695 - $228,017	377 Added 3.99%	9,822 $5.66 Million
Q4 2022 Feb 07, 2023	BUY	$484.71 - $571.37 $22,781 - $26,854	47 Added 0.5%	9,445 $5.2 Million
Q3 2022 Nov 09, 2022	SELL	$507.19 - $604.49 $690,285 - $822,710	-1,361 Reduced 12.65%	9,398 $4.77 Million
Q2 2022 Aug 09, 2022	BUY	$500.9 - $612.21 $93,167 - $113,871	186 Added 1.76%	10,759 $5.85 Million
Q1 2022 May 12, 2022	BUY	$524.0 - $644.92 $398,240 - $490,139	760 Added 7.74%	10,573 $6.24 Million
Q4 2021 Feb 11, 2022	BUY	$569.0 - $667.24 $237,273 - $278,239	417 Added 4.44%	9,813 $6.55 Million
Q3 2021 Nov 09, 2021	BUY	$509.53 - $609.78 $249,160 - $298,182	489 Added 5.49%	9,396 $5.37 Million
Q2 2021 Aug 09, 2021	BUY	$441.0 - $508.24 $85,995 - $99,106	195 Added 2.24%	8,907 $4.49 Million
Q1 2021 May 13, 2021	BUY	$439.85 - $518.83 $160,985 - $189,891	366 Added 4.39%	8,712 $3.98 Million
Q4 2020 Feb 11, 2021	BUY	$435.06 - $527.66 $259,730 - $315,013	597 Added 7.7%	8,346 $3.89 Million
Q3 2020 Nov 13, 2020	SELL	$359.77 - $441.52 $32,019 - $39,295	-89 Reduced 1.14%	7,749 $3.42 Million
Q2 2020 Aug 04, 2020	SELL	$275.2 - $362.34 $5,779 - $7,609	-21 Reduced 0.27%	7,838 $2.84 Million
Q1 2020 May 12, 2020	BUY	$255.3 - $340.05 $208,580 - $277,820	817 Added 11.6%	7,859 $2.23 Million
Q4 2019 Feb 13, 2020	BUY	$271.93 - $328.04 $42,693 - $51,502	157 Added 2.28%	7,042 $2.29 Million
Q3 2019 Nov 13, 2019	BUY	$268.46 - $305.43 $39,195 - $44,592	146 Added 2.17%	6,885 $2.01 Million
Q2 2019 Aug 13, 2019	SELL	$257.51 - $295.55 $875,534 - $1 Million	-3,400 Reduced 33.53%	6,739 $1.98 Million
Q1 2019 May 08, 2019	BUY	$212.17 - $273.72 $36,068 - $46,532	170 Added 1.71%	10,139 $2.78 Million
Q4 2018 Feb 01, 2019	BUY	$208.47 - $251.98 $109,655 - $132,541	526 Added 5.57%	9,969 $2.23 Million
Q3 2018 Nov 08, 2018	BUY	$205.57 - $244.32 $79,144 - $94,063	385 Added 4.25%	9,443 $2.31 Million
Q2 2018 Aug 08, 2018	BUY	$203.14 - $219.53 $83,490 - $90,226	411 Added 4.75%	9,058 $1.88 Million
Q1 2018 May 10, 2018	BUY	$192.98 - $224.11 $65,227 - $75,749	338 Added 4.07%	8,647 $1.79 Million
Q4 2017 Feb 12, 2018	BUY	$182.03 - $200.37 $1.51 Million - $1.66 Million	8,309	8,309 $1.58 Million

Others Institutions Holding TMO

# of Institutions

2,829

Shares Held

334M

Call Options Held

2.37M

Put Options Held

2.75M

View Full List

About THERMO FISHER SCIENTIFIC INC.

Ticker TMO
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 391,788,992
Market Cap $201B
Description
Thermo Fisher Scientific Inc. offers life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and service worldwide. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as di...

More about TMO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Providence Capital Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Providence Capital Advisors, LLC with notifications on news.

Account

Providence Capital Advisors, LLC Thermo Fisher Scientific Inc. Transaction History